- Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings.
- Retrospective study finds that the flu vaccine has benefits against severe effects of COVID-19. How it does this remains unknown but if true, it will be fascinating and enlightening to figure out how our immune response works in this setting.
- Small in vitro study suggests two new COVID subvariants may dodge natural immunity response. However whether this translates into worsening clinical outcomes remains unanswered.
- A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.